Investigation of the allosteric pharmacology of the 5-HT\(_3\) receptor identifying the potent allosteric modulator 5-chloroindole
[摘要] The 5-HT\(_3\) receptor is a ligand-gated ion channel that mediates for example fast synaptic neurotransmission in the CNS and PNS. 5-HT\(_3\) receptor antagonists are established anti-emetics in the clinic, they also offer symptomatic relief for patients with irritable bowel syndrome, yet, sometimes serious side-effects limits their use in this indication. The 5-HT\(_3\) receptor is modulated allosterically by various compounds including colchicine, alcohols and volatile anaesthetics but as yet, these modulators either lack potency or selectivity, which hinders investigation. The present study reports a novel 5-HT\(_3\) receptor allosteric modulator that displays relatively high potency and selectivity; 5-chloro-indole (Cl-indole). Cl-indole potentiated 5-HT\(_3\) receptor mediated responses arising from heterologous expression of the h5-HT\(_3\)A receptor (assessed by the affinity shift of agonists to compete for the radioligand binding site and by the increase in agonist action upon the h5-HT\(_3\)A receptor-mediated increase in [Ca\(^2\)\(^+\)]i; the latter action was evident with a range of agonists with very low intrinsic activity to full agonists). Cl-indole was also able to modulate allosterically the mouse native 5-HT\(_3\) receptor. Additional studies provided further support for the role of the C-terminus of the h5-HT\(_3\)A subunit to promote stability of the arising 5-HT\(_3\) receptor complex and that ligand interaction with the 5-HT\(_3\)A receptor impacted cell surface expression. In summary, the study reports the identification of Cl-indole as a positive allosteric modulator of the 5-HT\(_3\) receptor along with extensions to our knowledge concerning a structural component of the 5-HT\(_3\)A subunit that promotes stability and the trafficking of the subunit into the cell membrane. These studies increase our understanding of the 5-HT\(_3\) receptor, which may contribute to the design of better drugs targeting this receptor for therapeutic benefit.
[发布日期] [发布机构] University:University of Birmingham;Department:School of Clinical and Experimental Medicine
[效力级别] [学科分类]
[关键词] R Medicine;RM Therapeutics. Pharmacology [时效性]